---
title: "Evaluation of the safety and efficacy of Continuous Dopaminergic Stimulation by intracerebroventricular administration of anaerobically conserved dopamine in Parkinson's disease at the motor fluctuation stage: Single-center pilot study"
euct_id: 2024-517566-42-00
eudra_ct_number: 2020-000155-12
status: Completed
sponsor: Centre Hospitalier Universitaire De Lille
canonical_url: "https://parkinsonspathways.com/trials/eu/2024-517566-42-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2024-517566-42-00"
ctis_last_updated: "2025-12-10T02:34:24.275250187"
source: EU Clinical Trials Information System (CTIS)
---
# Evaluation of the safety and efficacy of Continuous Dopaminergic Stimulation by intracerebroventricular administration of anaerobically conserved dopamine in Parkinson's disease at the motor fluctuation stage: Single-center pilot study

**EU CT Number:** [2024-517566-42-00](https://euclinicaltrials.eu/ctis-public/view/2024-517566-42-00)

## Key Facts

- **Status:** Completed
- **Sponsor:** Centre Hospitalier Universitaire De Lille
- **Start Date:** 2020-09-18
- **Completion Date:** 2025-06-30
- **Conditions:** Parkinson's disease

## Member States

Trial is authorized in 1 member state: France.

## Sites (1)

- Centre Hospitalier Universitaire De Lille, Lille Cedex, France

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson's disease
Age groups: adults 18-64, elderly 65+
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2024-517566-42-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2024-517566-42-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2024-517566-42-00*